Cargando…
New molecular and immunotherapeutic approaches in biliary cancer
Biliary tract carcinoma is a collective term for a group of rare gastrointestinal cancers. This overview outlines the key pathways and specialised therapeutics in biliary cancer and the emerging role of immunotherapy by highlighting the rationale and selected examples of studies in each area.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
ESMO Open
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559907/ https://www.ncbi.nlm.nih.gov/pubmed/28848675 http://dx.doi.org/10.1136/esmoopen-2016-000152 |
| _version_ | 1783257598455185408 |
|---|---|
| author | Goldstein, David Lemech, Charlotte Valle, Juan |
| author_facet | Goldstein, David Lemech, Charlotte Valle, Juan |
| author_sort | Goldstein, David |
| collection | PubMed |
| description | Biliary tract carcinoma is a collective term for a group of rare gastrointestinal cancers. This overview outlines the key pathways and specialised therapeutics in biliary cancer and the emerging role of immunotherapy by highlighting the rationale and selected examples of studies in each area. |
| format | Online Article Text |
| id | pubmed-5559907 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | ESMO Open |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55599072017-08-28 New molecular and immunotherapeutic approaches in biliary cancer Goldstein, David Lemech, Charlotte Valle, Juan ESMO Open Review Biliary tract carcinoma is a collective term for a group of rare gastrointestinal cancers. This overview outlines the key pathways and specialised therapeutics in biliary cancer and the emerging role of immunotherapy by highlighting the rationale and selected examples of studies in each area. ESMO Open 2017-03-27 /pmc/articles/PMC5559907/ /pubmed/28848675 http://dx.doi.org/10.1136/esmoopen-2016-000152 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Review Goldstein, David Lemech, Charlotte Valle, Juan New molecular and immunotherapeutic approaches in biliary cancer |
| title | New molecular and immunotherapeutic approaches in biliary cancer |
| title_full | New molecular and immunotherapeutic approaches in biliary cancer |
| title_fullStr | New molecular and immunotherapeutic approaches in biliary cancer |
| title_full_unstemmed | New molecular and immunotherapeutic approaches in biliary cancer |
| title_short | New molecular and immunotherapeutic approaches in biliary cancer |
| title_sort | new molecular and immunotherapeutic approaches in biliary cancer |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559907/ https://www.ncbi.nlm.nih.gov/pubmed/28848675 http://dx.doi.org/10.1136/esmoopen-2016-000152 |
| work_keys_str_mv | AT goldsteindavid newmolecularandimmunotherapeuticapproachesinbiliarycancer AT lemechcharlotte newmolecularandimmunotherapeuticapproachesinbiliarycancer AT vallejuan newmolecularandimmunotherapeuticapproachesinbiliarycancer |